Avai Bio Inc Sustainability Reports
The company is an emerging biotechnology enterprise focused on identifying genetically modified cell lines and developing innovative cell-based therapies. Its development projects include specialized cellular treatments for diabetes management and age-related conditions.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG00L33D0V4
2 reports from 2024 to 2025
Company Profile
The company is an emerging biotechnology enterprise focused on identifying genetically modified cell lines and developing innovative cell-based therapies. Its development projects include specialized cellular treatments for diabetes management and age-related conditions.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
